CINF vs EBS
Cincinnati Financial Corporation (CINF) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Cincinnati Financial Corporation (CINF) is a insurance - property & casualty company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CINF revenue for 2024-12-31 was $11.34B. Net income was $2.29B. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. CINF currently screens at market cap $22.83B and trailing P/E 15.9.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CINF currently screens at market cap $22.83B and trailing P/E 15.9. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CINF and EBS stock pages for the full models.
Not investment advice.